More importantly, colorectal cancer patients with SARS-CoV-2 infection exhibited higher rates of lymphopenia, higher levels of hypersensitive C-reactive protein and a higher death rate than COVID-19 patients without colorectal cancer [23]. This evidence concerns the gene CRP and COVID-19.